uniformity, and variant call accuracy from FFPE TNA and DNA. For example, a single pool of 8 RNA and 16 DNA libraries yielded >500,000 reads for each library, with RNA fusions called with 189 to 11,274 reads and DNA mutations detected down to 5% variant allele frequency. Variant calls were 100% concordant with independent results and included mutations in EGFR, RAS, PIK3CA, and BRAF, along with fusions in ALK, RET, and NRG1 and skipped METex14. Conclusion: The co-detection strategy generated reliable quantitative information from low-input tumor FFPE DNA and TNA within three days. The simplicity and speed of the approach, coupled with a standardized workflow, has the potential to increase the accessibility of NGS analysis and accelerate the return of results for NSCLC patients.
Background: Lung cancer is staged according to TNM classification, which encodes the anatomic extent of the disease. This is the most important prognostic factor in patients diagnosed with lung cancer. CT scan is a basic imaging modality used for pre-treatment tumour staging (T staging). Each centimetre increase in size leads to worsening of prognosis. Adjuvant treatment decisions are based upon the final histopathological tumour size. Accurate clinical and pathologic correlation has been an important focus of research in many cancers. The objective of our study is to see for any discordance with respect to tumour size calculated by CT scan and final histopathological specimen in patients of carcinoma lung undergoing upfront surgery. Method: All patients of lung cancer operated upfront between 2012 to 2017 were included in the study. Any patient with chest wall involvement, significant pleural effusion and tumours of main bronchus were excluded. CT scans were acquired from the supraclavicular region through the adrenal glands using a 1.25 mm slice thickness with 1.25 mm spacing following deep inspiration. Based on tumour perimeter maximum tumour size was calculated. The largest diameter of resected lung tumour was recorded using a standard ruler by the pathologist. A mean, median and range for both the CT diameter and pathology diameter were obtained. A paired t-test was used to examine the measurement difference between CT and pathology. Result: A total of 109 patients were included in the study. Most common histology was Squamous cell carcinoma (n¼40,36%), followed by Adenocarcinoma (n¼32,29.3%), Neuroendocrine tumour(n¼27,24.77%) and other histologies (n¼10,9.17%). Among these patients, 22 tumours were located in right upper lobe (20.18%), 10: right middle lobe (9.17%), 25:right lower lobe(22.93%), 31: left upper lobe(28.44%) and 21: left lower lobe(19.26%). The mean size of tumour on CT scan is 4.92cm (SD¼1.852cm, range:1-10 cm) and mean size on grossing is 4.5cm(SD¼1.774cm,range:0.5-9.5cm)(p<0.05). The difference between the CT diameter and histopathological size is statistically significant. Tumour location and histology did not add any difference to tumour shrinkage. Conclusion: Our study demonstrates that there is a statistically significant difference between tumour diameter as measured by CT and its pathologic size. These differences could have implications in the treatment and prognosis of patients with lung cancer. Keywords: Pathology, lung cancer, imaging P3.09-23 Accuracy and Reproducibility of Touch Imprint Cytology in Resected Lung Cancer M. Kakihana, M. Hagiwara, Maeda J, Y. Shimada, S. Maehara, N. Kajiwara, T. Ohira, N. Ikeda General Thoracic Surgery, Tokyo Medical University, Tokyo/JP Background: With the development of high-resolution computed tomography (CT), small-sized tumors showing ground-glass opacity (GGO) on chest CT images has been more frequently encountered. However, methods such as the transbronchial biopsy and the computed tomography-guided fine-needle aspiration cytology are limited in their ability to diagnose such small lung tumors. We evaluated about the association of the cytological features with the histological examination using the surgically resected specimen. Method: 169 patients, age between 31e87 years old, who showed radiological signs of peripheral lung tumors less than 3.0cm in diameter on CT images, underwent surgical resection at our institution between 2015 and 2016. The histological examination was performed on surgical specimen, fixed with 10% formalin and stain with HematoxylineEosin. The cytological examination was performed on stamps from surgical material by Papanicolaou staining. The morphological features were compared both histopathogical diagnosis and cytological diagnosis of imprint cyotology derived from the resected specimen. Interobserver reproducibility was assessed by Kappa coefficient providing a measure for agreement beyond chance. Result: By histological examination (in the 169 cases), the diagnostic of lung cancer was given with the establishing of the histological type. In 139 cases (82.2%) of the cases diagnosed as adenocarcinoma, in 25 cases (14.8%) squamous cell carcinoma, in 3cases (1.7%) was neuroendocrine tumors, and one case each of adenosquamous carcinoma and pleomorphic carcinoma. There was 86.3% (146 of 169 cases) agreement with a k statisticvalue of 0.65. Obtained kappa values from imprint cytology showed good (from 0.60 to 0.8) for detection of epithelial cell abnormalities indicating high observer diagnostic reproducibility. Conclusion: This kappa statistic method allows assessment of the diagnostic quality of a respiratory cytology. Imprint cytology for small peripheral lung cancer is a useful method for evaluating tumors. Our data indicate the fact that the cytological examination on stamps from surgical material offers a very high percentage of positive results, close to the histological one. But in the tumor size less than 1.0cm, the establishing of the histological type of lung cancer is more difficult by cytological examination. Despite this, the cytology may be extremely useful in diagnose of the small peripheral tumors. The cytological characteristics of small peripheral adenocarcinoma were little reference to the differentiation at the cellular level. Our findings indicated that the presence of several nucleoli and granular chromatin densely are the factors of adenocarcinoma. Keywords: ground-glass opacity cytology reproducibility Background: Advances in radiological and diagnostic technics have improved the evaluation of pulmonary nodules, leading to an increase in preoperative histological diagnosis. For thoracic surgeons, it is important to know histological types of lung cancer preoperatively for the determination of surgical treatment strategy. The aim of this study is to evaluate the concordance of histological types between biopsy and resected specimens. Method: A total of 653 patients with primary lung cancer were operated on in our hospital between January 2013 to March 2018. Among them there were 438 patients who underwent bronchofiberscopic examination, and 364 patients (83.1%) were diagnosed preoperatively as lung cancer. We retrospectively reviewed 316 patients who underwent both transbronchial biopsy (TBB) and then surgical resection for primary lung cancer between January 2013 to March 2018. We compared diagnosed histological types, examined the accuracy of preoperative diagnosis by TBB, and evaluated the concordance between those two kinds of specimens. Result: In 302 of the 316 patients (95%), the histological types of lung cancer diagnosed from TBB matched those from resection specimens (k¼0.878). Concordance rate was the highest in adenocarcinoma (243/245; 99%), followed by squamous cell carcinoma (52/55; 95%). On the other hand, it was only 50% in neuroendocrine carcinoma (small cell carcinoma and LCNEC ± combined with adenocarcinoma / squamous cell carcinoma). Due to histological heterogeneity, 6 of 14 patients were diagnosed with different types of postoperative diagnosis, and four were due to the inconsistency of immunohistochemical (IHC) staining between biopsy and resected specimens. Conclusion: We considered that lung cancer has not only histological heterogeneity but also IHC heterogeneity. If larger samples are taken, the preoperative diagnosis of histological type could be more reliable. Background: A significant proportion of lung cancer patients presents at an advanced disease stage. Diagnosis and treatment in these patients is frequently based on small tissue samples such as fine needle biopsies. Eligibility for pembrolizumab immunotherapy requires assessment of the PD-L1 expression. Data on the concordance of PD-L1 assessment by immunohistochemistry between quantitatively limited samples, in particular cytology specimens, and resections are scant. We studied PD-L1 in formalin-fixed paraffin-embedded (FFPE) cell block sections of CT-guided transthoracic fine needle biopsies in comparison with the subsequent resection specimens of the primary lung tumors. Method: Paired specimens of fine needle biopsy-derived cell blocks and subsequent lung tumor resections of the same anatomic site were obtained from the archives of the Department of Pathology, University Health Network. Cell blocks were produced from normal saline needle rinse fluids fixed with a final concentration of 10% neutral-buffered formalin and processed using the Histogel method for paraffin-
